Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/11428
Title: Doxycycline vs. macrolides in combination therapy for treatment of community-acquired pneumonia.
Authors: Teh, B;Grayson, M Lindsay;Johnson, Paul D R;Charles, Patrick G P
Affiliation: Department of Infectious Diseases, Austin Health, Heidelberg, Vic., Australia.
Issue Date: 27-Jan-2012
Citation: Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2012; 18(4): E71-3
Abstract: We assessed the comparative efficacy of empirical therapy with beta-lactam plus macrolide vs. beta-lactam plus doxycycline for the treatment of community-acquired pneumonia (CAP) among patients in the Australian Community-Acquired Pneumonia Study. Both regimens demonstrated similar outcomes against CAP due to either 'atypical' (Chlamydophila, Legionella or Mycoplasma spp.) or typical bacterial pathogens.
Internal ID Number: 22284533
URI: http://ahro.austin.org.au/austinjspui/handle/1/11428
DOI: 10.1111/j.1469-0691.2011.03759.x
URL: http://www.ncbi.nlm.nih.gov/pubmed/22284533
Type: Journal Article
Subjects: Adult
Aged
Aged, 80 and over
Anti-Bacterial Agents.therapeutic use
Australia.epidemiology
Chlamydophila.pathogenicity
Community-Acquired Infections.drug therapy.epidemiology.microbiology
Doxycycline.therapeutic use
Drug Therapy, Combination
Female
Gram-Negative Bacterial Infections.drug therapy.epidemiology.microbiology
Humans
Legionella.pathogenicity
Macrolides.therapeutic use
Male
Middle Aged
Mycoplasma.pathogenicity
Mycoplasma Infections.drug therapy.epidemiology.microbiology
Pneumonia, Bacterial.drug therapy.epidemiology.microbiology
Prospective Studies
Severity of Illness Index
Treatment Outcome
Young Adult
beta-Lactams.therapeutic use
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.